BioSpace News Archive

Business

Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the first quarter ended March 31, 2023.

May 15, 2023
·
7 min read
Business

9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023

9 Meters Biopharma, Inc., a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, provided a business update and announced financial results for the first quarter ended March 31, 2023.

May 15, 2023
·
5 min read
Biotech Bay

Magnus Medical Shares New Study Results That Find Treatment With SAINT for Severe Depression Changes Abnormal Brain Signals

Magnus Medical, Inc. shared promising results from a clinical trial published in the Proceedings of the National Academy of Sciences indicating that treatment with SAINT™ Neuromodulation reverses abnormal brain signaling by changing the direction of brain signal flow in people with severe depression.

May 15, 2023
·
4 min read
BioForest

In Evolution Debate Intelligent Design Passes the Richard Dawkins Test, says Discovery Institute

Biologist and famed atheist Richard Dawkins has repeatedly described a test that he predicted would prove evolution, but now, mounting scientific evidence shows that the same test instead proves intelligent design, says Discovery Institute’s Center for Science & Culture.

May 15, 2023
·
2 min read
Business

Reviva Reports First Quarter 2023 Financial Results and Recent Business Highlights

Reviva Pharmaceuticals Holdings, Inc. today reported financial results for the first quarter ended March 31, 2023 and summarized recent business highlights.

May 15, 2023
·
9 min read
Policy

Celyad Oncology announces receipt of Nasdaq delisting notice

Celyad Oncology, is a biotechnology company focused on innovative technologies for chimeric antigen receptor T-cell therapies.

May 15, 2023
·
5 min read
Business

Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business Operations

Aprea Therapeutics, Inc. reported financial results for the three months ended March 31, 2023 and provided a business update.

May 15, 2023
·
10 min read
Business

STRATA Skin Sciences Reports First Quarter 2023 Revenue

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the first quarter ended March 31, 2023.

May 15, 2023
·
11 min read
Business

iCAD Reports Financial Results for First Quarter Ended March 31, 2023

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, reported its financial and operating results for the three months ended March 31, 2023.

May 15, 2023
·
17 min read
Business

CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

CorMedix Inc. announced financial results for the first quarter ended March 31, 2023 and provided an update on recent business developments.

May 15, 2023
·
8 min read